Protective STA-MCA bypass to prevent brain ischemia during high-flow bypass surgery: case series of 10 patients.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
06 2019
Historique:
received: 01 02 2019
accepted: 09 04 2019
pubmed: 2 5 2019
medline: 14 4 2020
entrez: 2 5 2019
Statut: ppublish

Résumé

High-flow extracranial-intracranial bypass is associated with a significant risk of ischemic stroke. The goal of this study is to evaluate the effectiveness of STA-MCA bypass preceding a high-flow bypass as a means of protecting the brain from ischemia during the high-flow bypass anastomosis in patients with otherwise untreatable aneurysms. This prospective study included 10 consecutive patients treated for complex/giant aneurysm using a previous combined STA-MCA bypass and high-flow EC-IC bypass between June 2016 and January 2018 when classical endovascular or microsurgical exclusion was estimated too risky. Early cranial Doppler, MRI, CT scan, and conventional angiography were performed in each patient to confirm patency of bypasses, measure flow in the anastomoses, detect any ischemic lesions, and evaluate exclusion of the aneurysm. The mean age at treatment was 55 years (range 34 to 67). The mean time of microsurgical procedure was 11 h (range 9 to 12). In all patients, the high-flow bypass was patent intraoperatively and complete occlusion of aneurysm was obtained. No ischemic lesions were noted on early MRI. One patient died from a large hemispheric infarction related to a common carotid artery dissection 10 days after the microsurgical procedure and immediate postoperative epidural hematoma was noted in one other patient. In this study, we described the use of a protective STA-MCA bypass, performed prior to the high-flow bypass, in order to reduce the risk of perioperative ischemic lesions without increasing the morbidity of the surgical procedure. This treatment paradigm was feasible in all ten patients without complications related to the STA-MCA anastomosis.

Sections du résumé

BACKGROUND
High-flow extracranial-intracranial bypass is associated with a significant risk of ischemic stroke. The goal of this study is to evaluate the effectiveness of STA-MCA bypass preceding a high-flow bypass as a means of protecting the brain from ischemia during the high-flow bypass anastomosis in patients with otherwise untreatable aneurysms.
MATERIALS AND METHOD
This prospective study included 10 consecutive patients treated for complex/giant aneurysm using a previous combined STA-MCA bypass and high-flow EC-IC bypass between June 2016 and January 2018 when classical endovascular or microsurgical exclusion was estimated too risky. Early cranial Doppler, MRI, CT scan, and conventional angiography were performed in each patient to confirm patency of bypasses, measure flow in the anastomoses, detect any ischemic lesions, and evaluate exclusion of the aneurysm.
RESULTS
The mean age at treatment was 55 years (range 34 to 67). The mean time of microsurgical procedure was 11 h (range 9 to 12). In all patients, the high-flow bypass was patent intraoperatively and complete occlusion of aneurysm was obtained. No ischemic lesions were noted on early MRI. One patient died from a large hemispheric infarction related to a common carotid artery dissection 10 days after the microsurgical procedure and immediate postoperative epidural hematoma was noted in one other patient.
CONCLUSION
In this study, we described the use of a protective STA-MCA bypass, performed prior to the high-flow bypass, in order to reduce the risk of perioperative ischemic lesions without increasing the morbidity of the surgical procedure. This treatment paradigm was feasible in all ten patients without complications related to the STA-MCA anastomosis.

Identifiants

pubmed: 31041595
doi: 10.1007/s00701-019-03906-4
pii: 10.1007/s00701-019-03906-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1207-1214

Commentaires et corrections

Type : CommentIn

Auteurs

Rabih Aboukais (R)

Department of Neurosurgery, Hospital Nord, Lille University Hospital, Rue E. Laine, 59037, Lille cedex, France. rabihdoc@hotmail.com.
INSERM, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, University of Lille, 59000, Lille, France. rabihdoc@hotmail.com.

Barbara Verbraeken (B)

Department of Neurosurgery, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.

Xavier Leclerc (X)

Department of Neuroradiology, Hospital Nord, Lille University Hospital, Lille, France.

Corinne Gautier (C)

Department of Neuroradiology, Hospital Nord, Lille University Hospital, Lille, France.

Maximilien Vermandel (M)

INSERM, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, University of Lille, 59000, Lille, France.

Nicolas Bricout (N)

Department of Neuroradiology, Hospital Nord, Lille University Hospital, Lille, France.

Jean-Paul Lejeune (JP)

Department of Neurosurgery, Hospital Nord, Lille University Hospital, Rue E. Laine, 59037, Lille cedex, France.
INSERM, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, University of Lille, 59000, Lille, France.

Tomas Menovsky (T)

Department of Neurosurgery, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH